WallStSmart

Corteva Inc (CTVA)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 53% more annual revenue ($27.29B vs $17.81B). NTR leads profitability with a 8.7% profit margin vs 5.7%. CTVA appears more attractively valued with a PEG of 1.32. NTR earns a higher WallStSmart Score of 57/100 (C).

CTVA

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 6.0Value: 5.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.49

NTR

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 6.5Value: 4.7Quality: 6.5
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CTVA.

NTRSignificantly Overvalued (-29.7%)

Margin of Safety

-29.7%

Fair Value

$56.34

Current Price

$77.09

$20.75 premium

UndervaluedFair: $56.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 9.0/10
Operating MarginProfitability
30.1%10/10

Strong operational efficiency at 30.1%

Market CapQuality
$55.98B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

NTR3 strengths · Avg: 8.7/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.99B8/10

Generating 2.0B in free cash flow

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
5.7%3/10

5.7% margin — thin

P/E RatioValuation
49.9x2/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

NTR4 concerns · Avg: 4.0/10
PEG RatioValuation
1.984/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

EPS GrowthGrowth
1.2%4/10

1.2% earnings growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Operating Margin, Market Cap, Debt/Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, P/E Ratio, Free Cash Flow.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 49.9x leaves little room for execution misses.

Bear Case : NTR

The primary concerns for NTR are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

NTR carries more volatility with a beta of 1.08 — expect wider price swings.

NTR is growing revenue faster at 4.0% — sustainability is the question.

NTR generates stronger free cash flow (2.0B), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NTR scores higher overall (57/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?